Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

NCT01009775

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of South Alabama Mobile, Alabama, United States

University of South Alabama Mobile, Alabama, United States

Arizona Clinical Research Center Tuscon, Arizona, United States

The Angeles Clinic and Research Los Angeles, California, United States

View all 13 locations

View Trial Details

Completed

Multicenter Selective Lymphadenectomy Trial (MSLT)

NCT00275496

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

NCT00723710

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

T-cell Based Immunotherapy for of Melanoma

NCT00937625

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark

View Trial Details

Completed

Videoscopic Ilioinguinal Lymphadenectomy for Melanoma

NCT02508909

Conditions: Lymphatic Metastasis, Melanoma, Neoplasm Metastasis, +15 more
Locations: Not specified

View Trial Details

Completed

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

NCT00518050

Conditions: Behavior, Health Behavior, Melanoma, +13 more
Locations: Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, United States

View Trial Details

Completed

A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma

NCT01672450

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

NCT02050594

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Caracas, Venezuela

View Trial Details

Completed

Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

NCT01681212

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Fukuoka, Japan

Local Institution Kumamoto, Japan

Local Institution Matsumoto-shi, Nagano, Japan

Local Institution Sunto-gun, Shizuoka, Japan

View Trial Details

Completed

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

NCT00110994

Conditions: Cancer, Melanoma, Neoplasms, +10 more
Locations: Tucson, Arizona, United States

Aurora, Colorado, United States

Lakeland, Florida, United States

Park Ridge, Illinois, United States

View all 14 locations

View Trial Details